Benefit:risk consideration in long-term therapy with dexfenfluramine.
Turner
P
P
Department of Clinical Pharmacology, St Bartholomew's Hospital, London, UK.
D005277:Fenfluramine / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D010919:Placebos; D012307:Risk Factors
D010919:Placebos; D005277:Fenfluramine